SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B

SUPPLEMENTARY DATA SUPPLEMENTARY MATERIALS AND METHODS
Genotyping of SOCS3 promoter variants
Genomic DNA was isolated from whole blood using a DNA purification kit (Qiagen, Hilden, Germany). The SOCS3 promoter region (nucleotides -1109 to -772) including two pre-described SNPs (rs111033850 and rs12953258) were amplified by PCR using primer pair SOCS3_PrF and SOCS3_PrR (Supplementary Table 1 ). PCR amplifications were carried out in a 25μl reaction volume containing (Qiagen): 1X PCR buffer, 0.2mM dNTPs, 1mM MgCl2, 0.15mM of each primer, 1unit of Taq polymerase and 50ng of genomic DNA. The cycling conditions were as follows: denaturation at 95°C for 5min, followed by 40 cycles of three-step cycling with denaturation at 94°C for 30s, annealing at 63°C for 35s, and extension at 72°C for 45s and a final extension at 72°C for 7min. PCR products were purified using Exo-SAP-IT (USB, Affymetrix, USA). 5μl of purified PCR products were used as templates. The sequencing was performed using the BigDye terminator v.1.1 cycle sequencing kit (Applied Biosystems, Foster city, USA) on an ABI 3130XL DNA sequencer according to the manufacturer's instructions. Sequencing results were finally analysed using vector NTI v.10 software.
SOCS3 mRNA expression
Total RNA was extracted from 37 dyads of liver biopsy tissues with Trizol reagent (Life Technologies). RNA was reverse transcribed into cDNA using QuantiTect Reverse Transcription Kit (Qiagen GmbH, Hilden, Germany). Quantification of cDNA was performed by qRT-PCR using SYBR Green PCR mix (Bioline, Germany). All reactions were performed in triplicate using the LightCycler ® 480 real-time PCR system (Roche, Switzerland). The GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene was used as a reference gene. In addition, the TGFBRAP-1 gene (transforming growth factor, beta receptor associated protein 1) was selected as an additional reference gene using Genevestigator (https:// genevestigator.com/gv/). The specific primers used for evaluating the SOCS3 mRNA expression were presented in the Supplementary Table 1 . The thermal cycling conditions were as follows: 2min at 95°C followed by 45 cycles of denaturation at 95°C for 5s and annealing at 58°C for 10s and extension at 72°C for 20s. The specificity of each reaction was confirmed by melting curve analysis. Calculation of normalized gene expression was based upon the ΔΔCT method. The fold change in SOCS3 expression was normalized to the expressed reference genes and then compared to the mean level expression in non-tumor tissues as the calibrator sample as follows: 
TGFBRAP-1_R 5'-GCG TCT GCT TCT GTT GCT GAT-3' SOCS3 mRNA expression
The specific primer pair SOCS3_PrF and SOCS3_PrR were designed to amplify nucleotides -1109 to -772 from start codon and were used for amplification and sequencing of the SOCS3 promoter region. Primers for fragment 1 were SOCS3_Fr1_F and SOCS3_Fr1_R [2] , primers for fragment 2 were SOCS3_Fr2_F and SOCS3_Fr2_R [3] , and primers for fragment 3 were SOCS3_Fr3_F and SOCS3_Fr3_R. These primers were designed to amplify nucleotides -1091 to -679; -704 to -186, and -295 to +60, respectively. The PCR amplification of the three fragments were performed as described previously (2;3). The specific primers used for evaluating the expression of SOCS3 mRNA were SOCS3_Exp_F and SOCS3_Exp_R [4] . Primers used for the reference genes were GAPDH_F and GAPDH_R (GAPDH) [5] and were TGFBRAP-1_F and TGFBRAP-1_R (TGFBRAP-1). 
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